Cefotaxime sodium salt CAS:64485-93-4
Cefotaxime sodium salt is prescribed by healthcare providers for the management of various bacterial infections such as respiratory tract infections, urinary tract infections, skin and soft tissue infections, sepsis, meningitis, and intra-abdominal infections. It is administered intravenously under medical supervision to ensure proper dosage and monitoring of therapeutic response. Healthcare professionals determine the appropriate dose of cefotaxime sodium salt based on factors like the patient's age, weight, renal function, and the specific type of infection being treated. Patients should adhere to the prescribed dosing schedule and complete the full course of treatment to effectively eradicate the bacterial infection and prevent potential relapse. While cefotaxime sodium salt is generally well-tolerated, patients should be monitored for possible side effects such as gastrointestinal disturbances, allergic reactions, or superinfections. Any severe or persistent adverse reactions should be promptly reported to a healthcare provider for evaluation and management. Overall, cefotaxime sodium salt is an important antimicrobial agent used in clinical practice for combating bacterial infections effectively when used judiciously and in accordance with medical guidance.
Composition | C16H18N5NaO7S2 |
Assay | 99% |
Appearance | white powder |
CAS No. | 64485-93-4 |
Packing | Small and bulk |
Shelf Life | 2 years |
Storage | Store in cool and dry area |
Certification | ISO. |